Nanox Vision

10/03/2026

What an incredible week at in Vienna!

From scientific presentations to meaningful conversations with the global radiology community, ECR 2026 was an exciting milestone for Nanox.

Highlights from the congress:

🏆 Named Newcomer of the Year

🎤 Scientific presentations
* Dr. Nogah Shabshin presented research on the potential role of digital tomosynthesis in improving lung cancer screening efficiency.
* Dr. Orit Wimpfheimer shared insights on how AI can activate latent data in routine CT scans to enable earlier detection of chronic diseases.

📊 Poster presentations
Our team presented multiple posters featuring new clinical data, including the new Tap2D feature, and new findings from the ADOPT AI study.

🖥 Live technology demonstrations
For the first time in Europe, we showcased the Nanox.ARC digital tomosynthesis system live, with ongoing demos highlighting its ability to deliver advanced 3D imaging with lower radiation and cost.

🤝 Community and networking
We were thrilled to host partners, collaborators, and radiology leaders during our ECR networking event and throughout the congress.

Thank you to everyone who visited our booth, attended our sessions, and joined the conversation about the future of accessible, AI-enabled medical imaging.

See you next year!

06/03/2026

What a fantastic evening at .

Nanox was proud to host a special event last night in Vienna, bringing together colleagues from across the radiology community for an engaging discussion on the future of imaging. We were thrilled to see a full room and such great energy throughout the evening.

A highlight of the event was the inspiring keynote presentation by Prof. Emilio Quaia, Professor of Radiology and Director of Radiology at the University of Padova, who presented “Beyond Chest X-ray: The Hidden Pathology Revealed by DTS” and shared valuable insights on the advantages of tomosynthesis and its potential impact on clinical practice.

Thank you to everyone who joined us and contributed to such a meaningful and lively discussion.

If you’re attending , we invite you to visit the Nanox team at Hall 4, Booth #425 to learn more about our technology and continue the conversation.

06/03/2026

Big news from hashtag ! 🎉

We’re honored and excited to share that Nanox has been named ECR 2026 Newcomer of the Year! 🏆

This recognition reflects the dedication of our incredible team and our mission to expand access to medical imaging worldwide.
Thank you to the European Congress of Radiology and to everyone who continues to support innovation in healthcare.
Congratulations to our amazing team pushing this mission forward every day!

If you’re still at the congress, there’s still time to stop by and meet the Nanox team at Hall 4, Booth #425.

hashtag

05/03/2026

Another great day at !

Yesterday, two of our experts shared insights on stage:

▪️ Orit Wimpfheimer, MD, Chief Medical Officer at Nanox, on how AI in CT imaging can help activate latent data for earlier detection
▪️ Dr. Nogah Shabshin, MD, MBA, BSc, on the potential clinical advantages of digital tomosynthesis for lung cancer screening

If you’re attending , there’s still time to stop by Hall 4, Booth #425 and connect with the Nanox team.

04/03/2026

Day 1 of hashtag is underway!

If you’re at the congress today, come visit the Nanox team at Hall 4, Booth #425. Our experts are on site and ready to connect with radiologists, healthcare leaders, and partners from around the world.

We look forward to meaningful conversations about the future of medical imaging and improving access to diagnostic technologies.

See you in Hall 4, Booth #425.

hashtag hashtag hashtag hashtag

24/02/2026

Proud to see Nanox featured in Applied Radiology ahead of our showcase at next week! We’ll be presenting our end-to-end medical imaging advancements: from the Nanox.ARC system to AI solutions designed to enhance early detection and support better clinical decision-making, all focused on expanding access and improving patient outcomes. Exciting to bring these advancements to ECR. Read more:

Nanox’s vision for global medical imaging development is transformational, a combination of hardware, software, and service delivery that applies unique design and AI-based advancements to expand care. At ECR in Vienna, March 4-8, 2026, the company will showcase its Nanox.ARC digital tomosynthesis...

19/02/2026

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution.

Collaboration with Intec SRL drives commercial expansion of 3D medical imaging across a high-growth private healthcare market.

This collaboration supports the continued expansion of Nanox.ARC across Latin America and strengthens our presence in the region’s private healthcare sector.

Read more here: https://investors.nanox.vision/news-releases/news-release-details/nanox-expands-latin-america-exclusive-nanoxarc-distribution

17/02/2026

Nanox is showcasing its end-to-end imaging solutions, from scan to diagnosis.

Demonstrating the cutting-edge, CE-marked Nanox.ARC in Europe for the first time, and proven results from Nanox.AI solutions.


Read today’s announcement: https://investors.nanox.vision/news-releases/news-release-details/nanox-showcase-nanoxarc-live-europe-first-time-and-present-new

Schedule a meeting with us to learn more:
https://outlook.office.com/bookwithme/user/d23d548e352e4149b2d2b4ff193e6272%40nanox.vision/meetingtype/juC_vUTwy0GHCc4ED0XmZQ2?anonymous&ismsaljsauthenabled&utm_source=linkedin&utm_medium=organic_social&utm_campaign=book_meeting

03/02/2026

TAP2D a new Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems

We’re proud to announce that Nanox has received FDA 510(k) clearance for TAP2D, a new image enhancement capability for Nanox.ARC and Nanox.ARC X Systems.
This milestone marks an important step forward toward the next phase of development, with the goal of ultimately removing the adjunct use in the U.S.
TAP2D provides radiologists with an additional, clear 2D image generated directly from the tomosynthesis scan, enabling both 3D and 2D views from a single scan, without exposing the patient to any additional radiation.

Learn more: https://investors.nanox.vision/news-releases/news-release-details/nanox-receives-fda-510k-clearance-tap2d-new-image-enhancement

24/06/2025

Nanox.ARC is reshaping hip imaging by delivering less than 7% of the radiation dose of an average CT scan, with a dose level almost identical to an average standard X-ray (only 1.1x higher).

This means patients benefit from enhanced diagnostic capabilities with minimal radiation exposure — making it a smart, safe choice for hip assessments.

Nanox.ARC: Precision you can trust, protection patients deserve.
https://www.nanox.vision/social-media-landing-page/

17/06/2025

When imaging extremities, Nanox.ARC offers a groundbreaking balance: delivering less than 2% of the radiation dose of a traditional CT scan — with approximately three times the dose of a standard X-ray.

Patients get diagnostic quality scans, providing additional information not available in Xray, with significantly reduced exposure over CT, helping to redefine safety and efficiency in medical imaging.

Discover a new era of smart imaging with Nanox.ARC: https://www.nanox.vision/social-media-landing-page/

10/06/2025

When it comes to imaging the lumbar spine, Nanox.ARC offers a remarkable balance between safety and clarity. With less than 9% of the radiation dose of an average CT scan, and only 20% additional dose to a standard X-ray, Nanox.ARC empowers providers to deliver more informed care — with minimal patient exposure.

Greater diagnostic value. Lower radiation burden.
This is spine imaging, reimagined.

Click here to learn more:
https://www.nanox.vision/social-media-landing-page/